Company / Revenue per Share
Ligand Pharmaceuticals, Inc. Revenue per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$14.03
FY2025
5-year range
$7.75 / $15.02
FY2021-FY2025
Trend
+47.4%
vs FY2024
Sector context
#37 of 154
Health Care
What the data says
Ligand Pharmaceuticals, Inc.'s revenue per share of $14.03 is higher than 76% of companies in the Health Care sector (FY2025). Revenue per Share has fluctuated over the past 10 years, ranging from $1.40 in FY2017 to $15.02 in FY2021.
Based on SEC 10-K filings.
14.03 in FY2025 with a 5-year CAGR of +7.6%. Top quartile in the Health Care sector.
Improved from $7.75 to $14.03 over the past 2 years.
Health Care sector context is included.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- +6.2%
- 5-Year CAGR
- +7.6%
- 10-Year CAGR
- -
Sector benchmark
-7.0% below sector average
Key checks
Key Insights
- In FY2025, revenue per share increased 47.4% year-over-year.
- Ranks #37 out of 154 companies in the Health Care sector.
- Peak revenue per share was recorded in FY2021.
- Lowest revenue per share in the period was in FY2017.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $14.03 | +47.4% |
| FY2024 | $9.52 | +22.9% |
| FY2023 | $7.75 | -33.8% |
| FY2022 | $11.70 | -22.1% |
| FY2021 | $15.02 | +54.5% |
| FY2020 | $9.72 | +67.9% |
| FY2019 | $5.79 | -51.3% |
| FY2018 | $11.89 | +749.4% |
| FY2017 | $1.40 | -74.4% |
| FY2016 | $5.46 | +48.7% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026